Bold claim first: fraud in Medicare and Medicaid costs Americans billions, and the new administration says it’s changing the game to stop that waste before it happens. But here’s where it gets controversial: some readers will question whether these measures will harm access to care or slow legitimate approvals. This rewritten version preserves all core facts and expands with clarification and context to help beginners grasp the issues.
Trump Administration Prioritizes Affordability by Announcing Major Crackdown on Health Care Fraud
WASHINGTON — February 25, 2026 — In a White House briefing, Vice President J.D. Vance, Health and Human Services Secretary Robert F. Kennedy, Jr., and CMS Administrator Dr. Mehmet Oz outlined a set of aggressive steps aimed at reducing fraud in Medicare and Medicaid. The objective is to safeguard patients and public funds while helping keep healthcare costs in check. The announced actions include:
- Deferring $259.5 million in quarterly federal Medicaid funding to Minnesota to halt questionable payments while investigations continue. This move emphasizes paying only for verified services.
- Implementing a nationwide moratorium on new Medicare enrollment for a broad category of Durable Medical Equipment, Prosthetics, Orthotics, and Supplies (DMEPOS) suppliers, to prevent new fraudulent inflows while enforcement actions proceed.
- Issuing a nationwide call to action encouraging Americans to participate in fraud prevention through the Comprehensive Regulations to Uncover Suspicious Healthcare (CRUSH) initiative. This effort invites stakeholder feedback on how CMS can expand and strengthen its fraud-fighting capabilities.
Taken together, these measures reflect a coordinated, data-driven approach designed to stop fraud before it starts, hold dishonest actors to account, and protect taxpayer dollars. HHS Secretary Kennedy explained that Medicare fraud has drained billions from taxpayers over the years, and that the administration intends to replace the old “pay and chase” model with a real-time “detect and deploy” strategy. This approach leverages advanced analytics and AI tools to identify suspicious activity instantly and stop improper payments before they are issued.
CMS Administrator Oz described the shift as moving beyond traditional reactionary enforcement. He characterized the new stance as tightening controls—like padlocking the cookie jar—so that fraudulent actors cannot benefit from deceptive practices and so that vulnerable Americans continue to receive the care they rely on. The aim, he said, is to reduce fraud, waste, and abuse, thereby lowering costs for all Americans and protecting program integrity.
For readers seeking more detail on CMS’s fraud prevention efforts, additional information is available at www.cms.gov/fraud. This suite of actions underscores a broader goal: improve affordability and ensure high-quality care for beneficiaries by eliminating financial leakage from the system.
What do you think about these steps? Do you expect real savings and better access to care, or do you worry about potential access barriers for legitimate suppliers and patients? Share your perspective in the comments to join the discussion.
